Living with or without cyclins and cyclin-dependent kinases
Open accessThe DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Entry into, progression through, and exit from the G1 phase of the mammalian cell cycle in response to extracellular mitogenic cues are presumed to be governed by cyclin-dependent kinases (Cdks) regulated by the D-type and E-type cyclins. Studies performed over more than a decade have supported the view that these holoenzymes are important, if not required, for these processes. However, recent experiments in which the genes encoding all three D-type cyclins, the two E-type cyclins, cyclin D-dependent Cdk4 and Cdk6, or cyclin E-dependent Cdk2 have been disrupted in the mouse germ line have revealed that much of fetal development occurs normally in their absence. Thus, none of these genes is strictly essential for cell cycle progression. To what extent is the prevailing dogma incorrect, and how can the recent findings be reconciled with past work?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite the high frequency of mutations epistatically targeting the RB signaling pathway in cancer cells, inactivation of the individual cyclin D, Cdk4/6, and Ink4a genes in mice, while leading to specific developmental defects when disrupted alone or in combination, established that their functions were nonessential for the cell cycle per se (62-64).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it may well prove that mutations affecting other cell cycle regulators, such as amplification of cyclin E, loss of p27Kip1 or p21Cip1 and activation of CDK2 would bypass the requirement of tumor cells for CDK4/6 activity, thereby also conferring de novo resistance (62-64).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [63]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370 · cited 1×
“…the idea that mutant " cancer stem cells, " rather than their differentiated progeny that may make up the bulk of a tumor, are the only cells strictly responsible for durable tumor maintenance and, in turn, for resistance to therapy (Reya et al. 2001; Taipale and Beachy 2001; Al-Hajj et al. 2003).”
BackgroundStem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738 · cited 2×
“The cells that give rise to many cancers have both the self-renewal and differentiating capacities of tissue stem cells, raising the idea that mutant “cancer stem cells,” rather than their differentiated progeny that may make up the bulk of a tumor, are the only cells strictly responsible for durable tumor maintenance…”
BackgroundCDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115 · cited 1×
“The AKT kinase controls the subcellular localization of Cip/Kip proteins as well (Liang et al. 2002; Shin et al. 2002; Viglietto et al. 2002), providing yet another avenue for cyclin E–Cdk2 regulation in response to extracellular cues.”
BackgroundSelf-citationA new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · cited 2×
“1994); conversely, attenuation of Cdk4 activity by polypeptide inhibitors of the INK4 gene family (Serrano et al. 1993) or by Cdk4-selective drugs (Tetsu and McCormick 2003) results in G1-phase arrest and cell cycle exit.”
BackgroundInhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243 · cited 6×
“1993), and by induction of polypeptide inhibitors of the Cip/Kip family in many physiologic settings (Sherr and Roberts 1995) result in G1-phase arrest.”
BackgroundInfluentialSelf-citationG1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,674 · cited 1×
“If this occurs before the G1/S boundary, cells exit the cycle without replicating their DNA, but if it occurs afterward, cells complete mitosis and exit from the cycle in the next G1 interval (Matsushime et al. 1994; Sherr 1994).”
BackgroundSelf-citationCYCLIN-DEPENDENT KINASES: Engines, Clocks, and Microprocessors
Morgan, D. O. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.261 · Cited by 2,259 · cited 3×
“The relevant proteins include three D-type cyclins (D1, D2, and D3) that, in different combinations, bind to, and allosterically regulate, one of two Cdk subunits, Cdk4 and Cdk6, as well as the E-type cyclins (E1 and E2), which, in analogous fashion, govern the activity of a single catalytic subunit, Cdk2 (Morgan 1997…”
BackgroundInfluentialGlycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130 · cited 2×
“…GSK-3, an enzyme that is inhibited by the phosphatidylinositol 3-kinase/AKT signaling pathway , in determining the stability of cyclin E implies that its life history, like that of cyclin D1 (Diehl et al. 1998), can be directly influenced by at least one mitogen-dependent kinase signaling cascade.”
BackgroundSelf-citationPolyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,954 · cited 1×
“, two potent inhibitors of Cdk2 (Polyak et al. 1994; Reynisdottir et al. 1995; Sherr and Roberts 1995).”
Self-citationCyclin D1 is a nuclear protein required for cell cycle progression in G1
Baldin, V, Lukas, J., Marcote, M. J., Pagano, M., & Draetta, G. (1993) · Genes & Development · doi:10.1101/gad.7.5.812 · Cited by 1,614 · cited 2×
“In continuously dividing cells, cyclin D1 exits the cell nucleus during S phase, and its turnover is accelerated throughout this interval (Baldin et al. 1993; Diehl et al. 1998), but Rasdependent cyclin D1 synthesis and its stabilization in G2 phase allow it to reaccumulate before cells divide (Guo…”
Background
Research works printed but not linked: 1
- Resnitzky, D., Gossen, M., Bujard, H., and Reed, S.I. 1994. Ac- celeration of the G1/S phase transition by expression of cy- clins D1 and E with an inducible system. Mol. Cell. Biol. 14: 1669-1679.
Cited by
Items 601–700 of 1,000
Vaccinia Virus Arrests and Shifts the Cell Cycle
Martin, C. K., Samolej, J., Olson, A. T., Bertoli, C., Wiebe, M. S., de Bruin, R. A. M., & Mercer, J. (2022) · Viruses · doi:10.3390/v14020431 · Cited by 22
The double-edged sword role of hydrogen sulfide in hepatocellular carcinoma
Zhao, H., Zhang, Y.-T. Y., Fu, X., Chen, C., Khattak, S., & Wang, H. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1280308 · Cited by 25
Evaluation of novel cell cycle inhibitors in mantle cell lymphoma
Park, I.-W., Reddy, M. V. R., Reddy, E. P., & Groopman, J. E. (2007) · Oncogene · doi:10.1038/sj.onc.1210350 · Cited by 21
“It is known that overexpression of cyclin D1 plays an important role in controlling the G1 progression and G1/S transition of the cell cycle (Sherr and Roberts, 1999; Kozar et al., 2004; Sherr and Roberts, 2004).”
BackgroundCardiac Progenitors and the Embryonic Cell Cycle
Goetz, S. C., & Conlon, F. L. (2007) · Cell Cycle · doi:10.4161/cc.6.16.4584 · Cited by 23
Cardone, A., Hassan, S. A., Albers, R. W., Sriram, R. D., & Pant, H. C. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.06.040 · Cited by 21
“(1) in Methods] is approximated by a time average over the last half of the dynamics, when major conformational changes have already set in.”
BackgroundInfluentialCDK4 deficiency promotes genomic instability and enhances Myc-driven lymphomagenesis
Lu, Y., Yong-sheng, W., Feng, X., Shen, R. Z., Wang, J. H., Fallahi, M., Li, W., Yang, C., Hankey, W., Zhao, W., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci63139 · Cited by 26
“CDK4:cyclin D complexes phosphorylate and inactivate the retinoblastoma (Rb) tumor-suppressor protein, releasing E2F transcription factors that regulate genes necessary for entry and progression through the S phase (15).”
Misexpression of cyclin D1 in embryonic germ cells promotes testicular teratoma initiation
Lanza, D. G., Dawson, E. P., Rao, P., & Heaney, J. D. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1149272 · Cited by 23
“Mice deficient for individual D-type cyclins are viable, fertile, and present with relatively minor phenotypes, demonstrating that these proteins are non-essential and likely have redundant functions in most normal cell lineages.(51,52)”
BackgroundTebufenozide induces G1/S cell cycle arrest and apoptosis in human cells
Xu, W., Wang, B., Yang, M., Zhang, Y., Xu, Z., Yang, Y., Cao, H., & Tao, L. (2016) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2016.12.002 · Cited by 21
Özsezen, S., Papagiannakis, A., Chen, H., Niebel, B., Milias‐Argeitis, A., & Heinemann, M. (2019) · Cell Systems · doi:10.1016/j.cels.2019.09.003 · Cited by 21
Defoe, D. M., Adams, L. B. S., Sun, J., Wisecarver, S. N., & Levine, E. M. (2007) · PubMed Central · Cited by 21
Tafuku, S., Ishikawa, C., Yasumoto, T., & Mori, N. (2012) · Oncology Reports · doi:10.3892/or.2012.1947 · Cited by 21
“The decrease in cell viability could be associated with a decreased cell proliferation and/or an increase in apoptotic cell death, and both D-type cyclins play a key role in cell proliferation through the activation of cyclin-dependent kinases (24).”
Hedgehog regulates Norrie disease protein to drive neural progenitor self-renewal
McNeill, B., Mazerolle, C. J., Bassett, E. A., Mears, A. J., Ringuette, R., Lagali, P. S., Picketts, D. J., Paes, K., Rice, D. S., & Wallace, V. A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds505 · Cited by 27
“5D), which promote entry into S-phase (32), and Cdk2, which is required for adult neural stem cell self-renewal (33).”
BackgroundLife without kinase: cyclin E promotes DNA replication licensing and beyond
Zhang, H. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.01.008 · Cited by 20
Mahalingam, C. D., Sampathi, B. R., Sharma, S., Datta, T., Das, V., Abou‐Samra, A., & Datta, N. S. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0372 · Cited by 21
Qi, Q., Kang, S. S., Zhang, S., Pham, C., Fu, H., Brat, D. J., & Ye, K.-N. (2017) · Oncogene · doi:10.1038/onc.2017.67 · Cited by 20
“CDK4 promotes proliferation by inhibiting the Rb1 tumor suppressor and by sequestering p27Kip1 and p21Cip1, thereby promoting E2F-and Cdk2-dependent cell cycle progression (8).”
Muscarella, P., Bloomston, M., Brewer, A., Mahajan, A., Frankel, W. L., Ellison, E. C., Farrar, W. B., Weghorst, C. M., & Li, J. (2008) · Gene Expression · doi:10.3727/105221608786883825 · Cited by 20
Selective chemical inhibition as a tool to study Cdk1 and Cdk2 functions in the cell cycle
Krasińska, L., Cot, E., & Fisher, D. (2008) · Cell Cycle · doi:10.4161/cc.7.12.6101 · Cited by 21
“Results of disrupting cyclin function in different animals have yielded conceptually similar results to G1 cyclin knockouts in yeast.(20) Cells can cycle in cyclin D mutants in drosophila, after cyclin D or cyclin E RNAi or mutation in nematodes, and in mice mutant for both E cyclins, or all three D-type cyclins.”
Han, J., Xiao, Y., Lin, J., & Li, Y. (2006) · Birth Defects Research Part B Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20094 · Cited by 20
Wierød, L., Rosseland, C. M., Lindeman, B., Oksvold, M. P., Grøsvik, H., Skarpen, E., & Huitfeldt, H. S. (2007) · Oncogene · doi:10.1038/sj.onc.1210937 · Cited by 22
“E-mail: lene.wierod@medisin.uio.no Oncogene (2008) 27, 2763–2771 & 2008 Nature Publishing Group All rights reserved 0950-9232/08 $30.00 www.nature.com/onc thereby promoting progression through the G1 phase of the cell cycle (Sherr and Roberts, 2004).”
BackgroundInfluentialJia, Y., Lin, J., Zeng, W., & Zhang, C. (2010) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2010.03.005 · Cited by 20
Cyclin-Dependent Kinase Inhibitors Block Leukocyte Adhesion and Migration
Liu, L., Schwartz, B. R., Tsubota, Y., Raines, E. W., Kiyokawa, H., Yonekawa, K. E., Harlan, J. M., & Schnapp, L. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1808 · Cited by 26
“Some of the mice have abnormalities in the hypothalamic-pituitary axis (47, 48) and develop diabetes due to abnormal pancreatic islet cell formation (17).”
BackgroundJantscher, F., Pirker, C., Mayer, C., Berger, W., & Sutterlüty, H. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-28 · Cited by 20
“Cyclin D1 (CCND1) is known to activate CDK4 and CDK6, a key event in mediating G1/ S transition [25].”
BackgroundChen, T., Wong, Y., & Zheng, W. (2009) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2009.09.006 · Cited by 20
RetractedBera, A., Sarkar, T., Upadhyay, A., & Hussain, A. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.216847 · Cited by 19
Salgado, M. T. S. F., Silva, E. F. E., Matsumoto, A. M., Mattozo, F. H., de Amarante, M. C. A., Kalil, S. J., & Votto, A. P. D. S. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105757 · Cited by 21
Jones, T. M., Espitia, C. M., Ooi, A., Bauman, J. E., Carew, J. S., & Nawrocki, S. T. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04798-6 · Cited by 19
“This inhibition of CDK4/6 results in the inhibition of Rb phosphorylation, which disallows the release of the transcription factor E2F1 [34].”
Immunohistological analysis of cell cycle and apoptosis regulators in thymus
Bai, M. C., Doukas, M., Papoudou‐Bai, A., Barbouti, A., Stefanaki, K. S., Galani, V., & Kanavaros, P. (2012) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2012.07.012 · Cited by 19
Fukui, T., Kishimoto, M., Nakajima, A., Yamashina, M., Nakayama, S., Kusuda, T., Sakaguchi, Y., Yoshida, K., Uchida, K., Nishio, A., et al. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-010-0364-8 · Cited by 22
Forti, F. L., & Armelin, H. A. (2007) · Endocrine Related Cancer · doi:10.1677/erc-07-0154 · Cited by 19
“In the cell cycle, regulation of G1 phase progression is characterized by a rigid sequential ordering of three gene transcription waves: first, immediate early genes; second, cyclin D genes; and third, cyclin E genes (Sherr 1993, Sherr & Roberts 1999, 2004).”
BackgroundLiu, H., Gong, M., French, B. A., Liao, G., Li, J., Tillman, B. C., & French, S. W. (2015) · Oncotarget · doi:10.18632/oncotarget.6382 · Cited by 19
“Cdkn2a and Cdkn2b genes encode p16 and p15 inhibitors of the G1/S phase of the cell cycle [5], and derepression of Cdkn2a has been suggested to induce cell death through downstream targets of p53, including p21 and Wig1 [6].”
BackgroundLi, Z., Zhou, Z., & He, Z. (2015) · PubMed · Cited by 21
Zhao, H., Mu, X., Zhang, X., & YOU, Q.-Y. (2020) · Medical Science Monitor · doi:10.12659/msm.922092 · Cited by 19
“and it is during this phase that progression to another stage of cell cycle is controlled by various intracellular and extracellular signals [23,24].”
BackgroundXiao, Y., Chen, Y., Peng, A., & Dong, J. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.11.018 · Cited by 20
Regulation of a Myb Transcription Factor by Cyclin-dependent Kinase 2 in Giardia lamblia
Cho, C., Su, L., Huang, Y.-C., Pan, Y.-J., & Sun, C.-H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.298893 · Cited by 19
Downregulation of Mdm2 and Mdm4 enhances viral gene expression during adenovirus infection
Yang, H., Zheng, Z., Zhao, L., Li, Q., & Liao, D. (2012) · Cell Cycle · doi:10.4161/cc.11.3.19052 · Cited by 19
Sal‐like protein 2 upregulates p16 expression through a proximal promoter element
Wu, Z., Cheng, K., Shi, L., Li, Z., Negi, H., Gao, G., Kamle, S., & Li, D. (2015) · Cancer Science · doi:10.1111/cas.12606 · Cited by 19
MicroRNA-218 inhibits the proliferation of human choriocarcinoma JEG-3 cell line by targeting Fbxw8
Shi, D., Tan, Z., Lu, R., Yang, W., & Zhang, Y. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.06.094 · Cited by 19
Saxena, U. H., Powell, C. M. H., Fecko, J. K., Cacioppo, R., Chou, H. S., Cooper, G. M., & Hansen, U. M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00687-08 · Cited by 20
Loss of p16 and high Ki67 labeling index is associated with poor outcome in esophageal carcinoma
Jacobsen, F., Kohsar, J., Gebauer, F., Kluth, M., Hube‐Magg, C., Simon, R., Bockhorn, M., Hinsch, A., Burandt, E., Lübke, A. M., et al. (2020) · Oncotarget · doi:10.18632/oncotarget.27507 · Cited by 20
“com The p16 tumor suppressor has been reported to play a pivotal role in cancer, since it inhibits cyclin-dependent kinases (CDKs) 4 and 6 at the G1 to S-phase transition of the cell cycle and thus prevents phosphorylation of the retinoblastoma (RB1) protein [5].”
BackgroundRole of the long non-coding RNAs in regulation of Gemcitabine response in tumor cells
Maharati, A., Samsami, Y., Latifi, H., Ghasaban, F. T., & Moghbeli, M. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03004-7 · Cited by 18
“Cyclin-dependent kinases (CDKs) have key roles in regulation of the cell cycle progression [139].”
BackgroundEpigenetic memories: structural marks or active circuits?
Nicol‐Benoit, F., Goff, P. L., Dréan, Y. L., Demay, F., Pakdel, F., Flouriot, G., & Michel, D. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0923-7 · Cited by 18
“ple, how to explain that when the celebrated actors of cell cycle (cyclins and CDK) are KO in mice, everything remains OK during the early embryonic development [73].”
BackgroundCyclin D2 rescues size and function of GATA4 haplo-insufficient hearts
Yamak, A., Temsah, R. M., Maharsy, W. M., Caron, S., Paradis, P., Aries, A., & Nemer, M. J. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00250.2012 · Cited by 23
Thiocoraline alters neuroendocrine phenotype and activates the N otch pathway in MTC ‐ TT cell line
Tesfazghi, S., Eide, J. G., Dammalapati, A., Korlesky, C., Wyche, T. P., Bugni, T. S., Chen, H., & Jaskula‐Sztul, R. (2013) · Cancer Medicine · doi:10.1002/cam4.118 · Cited by 18
“The cell cycle inhibitors, p21 and p27 have been shown to be crucial regulators of the cell cycle [24].”
BackgroundCheah, P., Looi, L., Teoh, K., Mun, K.-S., & Nazarina, A. R. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.2.469 · Cited by 18
“Hypophosphorylated pRb in turn sequesters E2F transcription factors as incompetent pRb-E2F complexes and prevents E2F from driving the G1-S transition of the cell cycle (Sherr and Roberts, 2004).”
BackgroundKomini, C., Theohari, I., Lambrianidou, A., Nakopoulou, L., & Trangas, T. T. (2021) · Journal of Cell Science · doi:10.1242/jcs.252304 · Cited by 20
Daniels, D. E., Ferguson, D. C. J., Griffiths, R. E., Trakarnsanga, K., Cogan, N. M., MacInnes, K. A., Mordue, K. E., Andrienko, T., Vicens, I. F., Jiménez, D. R., et al. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.06.002 · Cited by 20
“Both CDK4 and CDK6 are activated by D-type cyclins to drive cell cycle progression from G1 to S phase.(41) In line with the increased levels seen in the immortalized lines, CDK4 is known to be increased in many tumor types.”
BackgroundEAPP: Gatekeeper at the crossroad of apoptosis and p21-mediated cell-cycle arrest
Andorfer, P., & Rotheneder, H. (2011) · Oncogene · doi:10.1038/onc.2010.639 · Cited by 19
“The cell cycle of all eukaryotes is controlled by cyclindependent kinases (CDKs), the catalytic partners of cyclins (Sherr and Roberts, 2004).”
BackgroundSandoval, R., Pilkinton, M. A., & Colamonici, O. R. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.07.014 · Cited by 19
“In the G0 and G1 phases, negative regulation is achieved by the pocket proteins family members, pRB, p107, and p130 [1,2,4].”
BackgroundSilencing of p29 Affects DNA Damage Responses with UV Irradiation
Chu, P., Yang, Y., Lu, Y., Chen, H.-T., Yu, L., & Chang, M.-S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3229 · Cited by 18
Rb and hematopoiesis: stem cells to anemia
Walkley, C. R., Sankaran, V. G., & Orkin, S. H. (2008) · Cell Division · doi:10.1186/1747-1028-3-13 · Cited by 22
“Through a series of sequential inhibitory phosphorylation events by cyclin dependent kinases (Cdk), Rb family members are inactivated and release E2F proteins which drive the cell through the G1 phase into S phase where cell division will occur independent of extracellular signals [3,4].”
Mori, K., Hirao, E., Toya, Y., Oshima, Y., Ishikawa, F., Nose, K., & Shibanuma, M. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-04-0428 · Cited by 20
“Recent studies on the cyclin D-null mouse have provided substantial information on the biological functions of cyclin D in vivo (Kozar et al., 2004; Sherr and Roberts, 2004).”
BackgroundChen‐Kiang, S. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2005.02.002 · Cited by 18
Reddy, H. K. D. L., Graña, X., Dhanasekaran, D. N., Litvin, J., & Reddy, E. P. (2010) · Genes & Cancer · doi:10.1177/1947601909358105 · Cited by 27
Carbazole–pyrrolo[2,1-c][1,4]benzodiazepine conjugates: design, synthesis, and biological evaluation
Kamal, A., Shetti, R. V. C. R. N. C., Ramaiah, M. J., Swapna, P., Reddy, K. S., Mallareddy, A., Rao, M. P. N., Chourasia, M., Sastry, G. N., Juvekar, A. S., et al. (2011) · MedChemComm · doi:10.1039/c1md00072a · Cited by 17
Quantum capacitance-limited MoS 2 biosensors enable remote label-free enzyme measurements
Le, S. T., Guros, N. B., Bruce, R. C., Cardone, A., Amin, N. D., Zhang, S., Klauda, J. B., Pant, H. C., Richter, C. A., & Balijepalli, A. K. (2019) · Nanoscale · doi:10.1039/c9nr03171e · Cited by 17
Kanagasabai, T., Venkatesan, T., Natarajan, U., Alobid, S. E., Alhazzani, K., Algahtani, M., & Rathinavelu, A. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109435 · Cited by 19
Jensen, L., Bartlett, J. M. S., Witton, C. J., Kirkegaard, T., Brown, S., Müller, S., Campbell, F., Cooke, T. G., & Nielsen, K. V. (2009) · Cancer Biomarkers · doi:10.3233/cbm-2009-0570 · Cited by 17
Expression Analysis of Genes Involved in the RB/E2F Pathway in Astrocytic Tumors
Ferreira, W. A. S., Araújo, M. D., Anselmo, N. P., de Oliveira, E. H. C., Brito, J. R. N., Burbano, R. M. R., Harada, M. L., & Borges, B. D. N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137259 · Cited by 17
“The INK4 family proteins (p16 and p15) bind to and inhibit the activity of CDK4 and CDK6, maintaining pRB in a hypophosphorylated state [112].”
BackgroundPhotobiological effect of low-level laser irradiation in bovine embryo production system
Soares, C. A., Annes, K., Dreyer, T. R., Magrini, T. D., Sonoda, M. T., Martinho, H. D. S., Nichi, M., Assumpção, M. E. O. D., & Milazzotto, M. P. (2014) · Journal of Biomedical Optics · doi:10.1117/1.jbo.19.3.035006 · Cited by 17
Microenvironmental Control of the Breast Cancer Cell Cycle
Guo, X., Wu, Y., Hathaway, H. J., & Hartley, R. S. (2012) · The Anatomical Record · doi:10.1002/ar.22417 · Cited by 18
“Correspondingly, the stroma contains a variety of cells (including fibroblasts, adipocytes, endothelial cells, smooth muscle, innate and adaptive immune cells, and nerve cells), as well as ECM proteins (Shekhar et al., 2003; Stein et al., 2004).”
BackgroundLiu, S., Tang, Y., Yuan, X., Yuan, D., Liu, J., Li, B., & Li, Y. (2018) · Investigational New Drugs · doi:10.1007/s10637-018-0575-z · Cited by 19
“CDK4/6 contributes proliferation via suppressing the Rb1 tumor suppressor and by sequestering p27Kip1 and p21Cip1, thereby promoting E2F- and Cdk2- dependent cell cycle progression [30].”
BackgroundZhou, Q., & Melton, D. A. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.72.002 · Cited by 17
“However, direct manipulations of cell cycle regulators often lead to cancer (Sherr and Roberts 2004).”
BackgroundMaros, M. E., Schnaidt, S., Balla, P., Kelemen, Z., Sápi, Z., Szendrői, M., László, T., Forsyth, R. G., Picci, P., & Krenács, T. (2019) · Bone · doi:10.1016/j.bone.2019.06.022 · Cited by 17
He, J., Zhao, Y., Zhang, Y., Zhang, Z., Li, D., & Xu, Q. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111098 · Cited by 18
Nobs, L., Nestel, S., Kulik, Á., Nitsch, C., & Atanasoski, S. (2013) · Glia · doi:10.1002/glia.22533 · Cited by 16
Profile of palbociclib in the treatment of metastatic breast cancer
Elbaz, M., & Ehab, M. (2016) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s83146 · Cited by 22
“31 Therefore, increasing the replication capacity which might result in tumorigenesis.”
Fluorescent Peptide Biosensor for Probing CDK6 Kinase Activity in Lung Cancer Cell Extracts
Soamalala, J., Diot, S., Pellerano, M., Blanquart, C., Galibert, M., Jullian, M., Puget, K., & Morris, M. C. (2020) · ChemBioChem · doi:10.1002/cbic.202000677 · Cited by 17
Kalderon, D. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-470-4_8 · Cited by 17
Cyclin D1 G870A polymorphism and risk of colorectal cancer: A case control study
Aga, S. S., Parray, F. Q., Dar, M., Nissar, S., Banday, M. Z., Rasool, S., Gulzar, G. M., Chowdri, N. A., & Siddiqi, M. A. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1287 · Cited by 16
Matsumoto, A., Takeishi, S., & Nakayama, K. I. (2014) · Blood · doi:10.1182/blood-2013-10-532390 · Cited by 16
“Progression of the cell cycle is controlled by pairs of cyclins and cyclin-dependent kinases (CDKs).(7) CDKs normally inactivate the retinoblastoma protein (Rb) by hyperphosphorylation and thereby activate E2F transcription factors,(8) which play a key role in cell cycle progression by regulating the transcription of…”
BackgroundQi, Q., He, K., Liu, X., Pham, C., Meyerkord, C. L., Fu, H., & Ye, K.-N. (2012) · Oncogene · doi:10.1038/onc.2012.109 · Cited by 18
Simmons, D. P., Peach, M. L., Friedman, J. R., Green, M. M. B., Nicklaus, M. C., & Luca, L. M. D. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi235 · Cited by 16
“This is reasonable since it has been shown that cytoplasmic cyclin E is capable of cdk2-independent S-phase entry ( 42 ) and that overexpression of cyclin E can result in accelerated S phase entry (43).”
BackgroundDeng, L., Xiang, X., Yang, F., Xiao, D., Liu, K., Chen, Z., Zhang, R., & Feng, G. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.06.016 · Cited by 16
“CCND1 is a regulatory subunit of the cyclind ependent kinases Cdk4/6, whose Ccnd1-dependent activity controls cell proliferatio n and development through its role as a transcriptional regulator[25][26].”
BackgroundGrison, A., Gaiser, C., Bieder, A., Baranek, C., & Atanasoski, S. (2018) · Developmental Neurobiology · doi:10.1002/dneu.22588 · Cited by 16
“Indeed, genetic manipulations of individual cell cycle genes in most cases still allow normal fetal develop- ment (reviewed Sherr and Roberts, 2004).”
BackgroundInfluentialGuinn, Z. P., & Petro, T. M. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.09.003 · Cited by 16
HO-1 is a favorable prognostic factor for HBV-HCC patients who underwent hepatectomy
Yeh, C., Wu, R., Cheng, C., Tsai, C., Chang, Y.-R., Yeh, T., Wu, T., Lee, W., & Chiang, K. (2018) · Cancer Management and Research · doi:10.2147/cmar.s186931 · Cited by 16
Webster, K. A., Henke, K., Ingalls, D. M., Nahrin, A., Harris, M. P., & Siegfried, K. R. (2019) · Reproduction · doi:10.1530/rep-18-0386 · Cited by 16
Animal Models for Studying the In Vivo Functions of Cell Cycle CDKs
Risal, S., Adhikari, D., & Liu, K. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2926-9_13 · Cited by 17
Identification of G1-Regulated Genes in Normally Cycling Human Cells
Beyrouthy, M. J., Alexander, K. E., Baldwin, A. E., Whitfield, M. L., Bass, H. W., McGee, D., & Hurt, M. M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003943 · Cited by 16
“We wanted to examine gene activity in early G1 phase of the cell cycle in human cells moving naturally from mitosis into a new cell cycle. Most of what is known about G1 phase regulation came originally from studies utilizing cells synchronized by serum starvation, contact inhibition, thymidine blocks or drugs”
BackgroundDifferential expression of cell cycle proteins during ageing of pancreatic islet cells
Hinault, C., Hu, J., Maier, B. F., Mirmira, R. G., & Kulkarni, R. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00947.x · Cited by 18
A system for studying evolution of life-like virtual organisms
Neyfakh, A. A., Baranova, N. N., & Mizrokhi, L. J. (2006) · Biology Direct · doi:10.1186/1745-6150-1-23 · Cited by 16
“This apparently excessive complexity is further confounded by the relatively recent realization that close to 80% of genes in the genomes are nonessential, in the sense that they can be individually knocked-out with only limited effect on the organism fitness [21-26].”
BackgroundProgress Towards the Anatomy of the Eukaryotic DNA Replication Fork
Nasheuer, H., Pospiech, H., & Syväoja, J. E. (2006) · Springer eBooks · doi:10.1007/7050_016 · Cited by 18
Role of Cdk4 in lymphocyte function and allergen response
Chow, Y. H., Zhu, X. D., Liu, L., Schwartz, B. R., Huang, X. Z., Harlan, J. M., & Schnapp, L. M. (2010) · Cell Cycle · doi:10.4161/cc.9.24.14209 · Cited by 15
Role of APR3 in cancer: apoptosis, autophagy, oxidative stress, and cancer therapy
Zhang, P., Zhou, C., Jing, Q., Gao, Y., Yang, L., Li, Y., Du, J., Tong, X., & Wang, Y. (2023) · APOPTOSIS · doi:10.1007/s10495-023-01882-w · Cited by 16
“The primary function of the cyclin D-CDK4 complex is to phosphorylate and inactivate the pocket protein [36, 37].”
BackgroundChiang, M., Cinquin, A., Paz, A., Meeds, E., Price, C. A., Welling, M., & Cinquin, O. (2015) · BMC Biology · doi:10.1186/s12915-015-0148-y · Cited by 16
Targeting cyclin D1 as a therapeutic approach for papillary thyroid carcinoma
Cai, W. L., Shu, L.-Z., Liu, D.-J., Zhou, L., Wang, M.-M., & Deng, H. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1145082 · Cited by 16
“In normal cells, the processes of expression, activation, distribution, stabilization, and degradation of cyclin D1 are strictly regulated by the on/off signal response of mitosis (21, 22).”
BackgroundArabidopsis PCNAs form complexes with selected D-type cyclins
Strzałka, W., Aggarwal, C., Krzeszowiec, W., Jakubowska, A., Sztatelman, O., & Banaś, A. K. (2015) · Frontiers in Plant Science · doi:10.3389/fpls.2015.00516 · Cited by 18
“The mammalian cyclins D1, D2, D3 and their partners CDK4 and CDK6 have been shown to act early in G1 phase (Sherr and Roberts, 2004).”
BackgroundFernandes, K. M., Auld, C. A., Hopkins, R. G., & Morrison, R. F. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21894 · Cited by 16
Pavlides, S. C., Lecanda, J., Daubriac, J., Pandya, U. M., Gama, P., Blank, S. V., Mittal, K., Shukla, P. S., & Gold, L. I. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1150393 · Cited by 17
“Cyclins bind to specific Cdks that phosphorylate pRB for progression to S phase; this activity is blocked by cyclin-dependent kinase inhibitors (CDKIs).(12) Inhibition of proliferation can be mediated by the upregulation of 2 families of mammalian CDKIs, ink4 proteins, p15, p16, p18, p19 and kip/cip proteins, p21, p27…”
BackgroundBelső, N., Gubán, B., Manczinger, M., Kormos, B., Bebes, A., Németh, I. B., Veréb, Z., Széll, M., Kemény, L. V., & Bata‐Csörgõ, Z. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.11.030 · Cited by 15
Engler, D. (2007) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · Cited by 21
Mitra, P., Ghule, P. N., van der Deen, M., Medina, R., Xie, R.-L., Holmes, W. F., Ye, X., Nakayama, K. I., Harper, J. W., Stein, J. L., et al. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21687 · Cited by 15
“At the restriction point that precedes the G1/S boundary, growth factor dependent signaling pathways activate cyclin E and its cognate cyclin dependent kinase 2 (CDK2) (Blagosklonny and Pardee, 2002; Sherr and Roberts, 2004).”
BackgroundMataraza, J., Tumang, J. R., Gumina, M. R., Gurdak, S. M., Rothstein, T. L., & Chiles, T. C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.787 · Cited by 18
Role of Cyclins and Cytoskeletal Proteins in Endometriosis: Insights into Pathophysiology
Szymański, M., Bonowicz, K., Antosik, P., Jerka, D., Głowacka, M., Soroka, M., Steinbrink, K., Kleszczyński, K., & Gagat, M. (2024) · Cancers · doi:10.3390/cancers16040836 · Cited by 15
“Notably, their concentration in the cell undergoes cyclic variations rather than remaining constant [14,15].”
BackgroundLiu, Y., Deng, Y., Yang, C., & Naranmandura, H. (2024) · Bioengineering · doi:10.3390/bioengineering11111084 · Cited by 17
The molecular landscape of AL amyloidosis
Zvida, T., Muchtar, E., Dispenzieri, A. A., Shpilberg, O., & Hershkovitz‐Rokah, O. (2025) · British Journal of Haematology · doi:10.1111/bjh.20070 · Cited by 14
Li, L., Zhang, G., Zhang, Y., Tan, J., Huang, H., Huang, B., & Lü, J. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9870-x · Cited by 14
“coordinated with cell cycle exit [12].”
Kishimoto, M., Fukui, T., Suzuki, R., Takahashi, Y., Sumimoto, K., Okazaki, T., Sakao, M., Sakaguchi, Y., Yoshida, K., Uchida, K., et al. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3348-3 · Cited by 16
Segment- and cell-specific expression of D-type cyclins in the postnatal mouse epididymis
Wang, H., & Kumar, T. R. (2012) · Gene Expression Patterns · doi:10.1016/j.gep.2012.01.003 · Cited by 21
“Cyclin D3 is usually not expressed in same cells that express cyclin D1 and D2 (Carthon et al., 2005; Kushner et al., 2005; Sherr and Roberts, 2004; Zhang et al., 1999).”
Nellore, A., Liu, B., Patsoukis, N., Boussiotis, V. A., & Li, L. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.02.015 · Cited by 14
“These studies showed that upon stimulation via TCR/CD3+CD28, Tcon cells – which eventually become effectors – displayed robust hyper-phosphorylation of Rb in multiple sites, which is a well-established consequence of the sequential activation of Cdk4/6 in the early G1 phase and the activation of Cdk2 in the late G1 an…”
Background
Metadata
- Authors
- Sherr, C. J., & Roberts, J. M.
- Affiliations
- St. Jude Children's Research Hospital (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2004-11-15
- Volume
- 18
- Issue
- 22
- Pages
- 2699-2711
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2152107294
- Cited by
- 1,089
- References
- 115
- Citations by year
- 2026: 13 · 2025: 36 · 2024: 48 · 2023: 38 · 2022: 34 · 2021: 42 · 2020: 49 · 2019: 50 · 2018: 36 · 2017: 35 · 2016: 42 · 2015: 51 · 2014: 47 · 2013: 52 · 2012: 62
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- cyclin-dependent kinases, cyclins, D-type cyclins, G1 phase, cell cycle progression, CDK4, CDK6, CDK2, cyclin E, cyclin D, fetal development, mitogenic signaling
- MeSH terms
- Animals, Cell Cycle, Humans, Signal Transduction, Cyclins, Mice, Knockout, Cyclin-Dependent Kinases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.